A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
Hamid Omid, Schmidt Henrik, Nissan Aviram, Ridolfi Laura, Aamdal Steinar, Hansson Johan, Guida Michele, Hyams, Gómez Henry, Bastholt Lars, Chasalow, Berman David